Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott Molecular
Age
25–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Is 25 years of age or older
Is attending a participating clinic for routine cervical cancer screening following screening guidelines
Has an intact cervix
Is willing and able to provide documented informed consent
Is willing and able to undergo colposcopy, biopsy, and endocervical curettage (ECC) within 12 weeks (≤ 84 days) from the baseline visit, if required
Is willing and able to allow collection of two cervical cytology specimens
You may not be if
A women is ineligible for the study if she meets any of the following criteria:
Is pregnant at the time of visit or plans to become pregnant within the following 12 weeks
Has any known medical condition that, in the opinion of the investigator, would result in increased risk of bleeding at biopsy
Has a known history of excisional or ablative therapy (e.g., LEEP, cone biopsy, cervical laser surgery, or cryotherapy) to the cervix in the last 12 months prior to the baseline visit
Had a cervical cytology specimen collected within the last 4 months
Is currently participating in any diagnostic trial for cervical cancer
Had a complete or partial hysterectomy, either supra cervical or involving removal of the cervix
Is currently participating or planning to participate in any clinical trial for HPV treatment (for the duration of this study)
Previous participation in this study
Clareo Health | Alinity m HR HPV Specimen Collection Study From Women Undergoing Routine Cervical Cancer Screening
